CompletedNot Applicable

A Soft Silicone Wound Contact Layer Containing Silver in the Treatment of Skin Grafts in Surgical Burn Patients.

United States25 participantsStarted 2014-09

Plain-language summary

Part A The primary objective of Part A will be to verify performance and safety of Mepitel® Ag, a meshed, non- adherent soft silicone wound contact layer containing silver in the treatment of skin grafts in surgical burn patients. Part B The primary objective of Part B will be to examine the usefulness of Mepilex® Transfer Ag as an adequate option for donor site healing.

Who can participate

Age range18 Months – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕There must be healthy, intact peri-wound skin surrounding the planned donor site to allow for adequate overlap of study product (5 cm)

What they're measuring

Part A: Number of Participants With Healing

Timeframe: 14 days

Part B

Timeframe: 14 days with 2 visits

Trial details

NCT IDNCT02210208

SponsorMolnlycke Health Care AB

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2016-06

Results submitted2017-07-05

View on ClinicalTrials.gov More Burn Injury trials